Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Low vitamin D3 is not linked to different levels of thyroid hormones in people with autoimmune thyroid disease.

Noncultured epidermal cell transplantation is effective for repigmenting stable vitiligo.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

Follicular red dots may be a normal feature seen in people with less skin pigmentation, not necessarily indicating a scalp disorder.

Child with rickets improved with a specific vitamin D therapy, but alopecia did not change.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

LRIG1 is linked to better survival in Merkel cell carcinoma.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Epidermal cysts come from the skin, while pilar cysts come from hair follicles.

Intracorneal vacuoles are common in parakeratotic skin diseases in dogs, especially with more parakeratosis.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Infliximab may cause hair loss in Crohn's disease patients.

Raltegravir may cause hair loss in some patients.

TRPV4 channel affects skin health and could be a target for treating skin disorders.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Platelet-rich plasma may improve vitiligo treatment when used with phototherapy.